IPEC Europe fully supports the proposed revision of the general pharmaceutical legislation and is pleased to be able to offer feedback as it pertains to pharmaceutical excipients. IPEC Europe represents the producers, the distributors of pharmaceuticals excipients as well as the pharmaceutical companies using excipients.
IE
IPEC Europe
Industry association · Belgium · EU Transparency Register 341962119314-36
2
positions filed
in the 665 files tracked
2
legislative files
of 665 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1518 trade and business associations on this site, they rank #1125 by legislative files engaged, a count of participation, not a measure of influence.
1
declared lobbying FTE
self-declared
< €10K
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2015
in the register since
Declares membership of
- IPEC Europe is member of IPEC Federation (ipec.org) and of EXCiPACT (excipact.org)
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Trade and business associations
- Registered as
- Le Conseil International des Excipients Pharmaceutiques - Europe (IPEC Europe)
- Head office
- Brussels, Belgium
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track IPEC in PolicySpeak: request access →
Work at IPEC Europe? so we know who speaks for it.
Their record over time
IPEC Europe filed 2 positions between 27 Apr 2021 and 4 Aug 2026, across 2 of the 665 legislative files tracked here, attaching a full position paper 1 time.
2021 · 1 filed2026 · 1 filed
What they argued
IPEC Europe welcomes the objectives of the proposed Biotech Act, particularly efforts to strengthen the resilience and strategic autonomy of the EU biotechnology ecosystem. However, the proposal does not explicitly recognise the essential role of pharmaceutical excipients in biotechnology value chains.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put IPEC Europe next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 73.
Is this your organization?
Everything on this page comes from IPEC Europe’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.